S 033447

Drug Profile

S 033447

Alternative Names: S-033447

Latest Information Update: 04 Jan 2017

Price : $50

At a glance

  • Originator Shionogi
  • Class Antivirals; Small molecules
  • Mechanism of Action Endonuclease inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Influenza A virus infections; Influenza B virus infections

Most Recent Events

  • 27 Oct 2016 Preclinical trials in Influenza-A virus infections in Japan (unspecified route)
  • 27 Oct 2016 Preclinical trials in Influenza-B virus infections in Japan (unspecified route)
  • 26 Oct 2016 Preclinical pharmacodynamics data presented at the Infectious disease Week-2016 (IDW-2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top